DoJ Takes Action On Insys For 'Unfair, Deceptive Marketing Practices' Of Fentanyl Drug
January 19, 2017 at 11:20 AM EST
Insys Therapeutics Inc (NASDAQ: INSY) is a commercial-stage specialty pharmaceutical company whose product Subsys is a sublingual ...